BioArctic AB (publ) (STO:BIOA.B)
178.20
-1.60 (-0.89%)
May 9, 2025, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
2.41M SEK
Profits / Employee
-1.65M SEK
Market Cap
15.78B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,204 |
Getinge AB | 11,791 |
Camurus AB | 256 |
Medicover AB | 47,256 |
AddLife AB | 2,181 |
Vitrolife AB | 1,169 |
Vimian Group AB | 1,200 |
BioArctic AB News
- 3 days ago - Exidavnemab phase 2a study expanded to include MSA patients - PRNewsWire
- 5 weeks ago - The European Commission refers lecanemab decision to Appeal Committee - PRNewsWire
- 6 weeks ago - BioArctic's partner Eisai presents sales simulation for Leqembi® at its annual press conference - PRNewsWire
- 7 weeks ago - BioArctic receives Orphan Drug Designation for exidavnemab the US - PRNewsWire
- 2 months ago - Therapeutic Goods Administration decides not to register lecanemab in Australia - PRNewsWire
- 2 months ago - The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU - PRNewsWire
- 2 months ago - Leqembi® sales reaches €200 million - first sales milestone achieved - PRNewsWire
- 3 months ago - FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US - Benzinga